China abstracts （结肠直肠癌）ppt课件.pptVIP

BOA Colorectal Cancer Abstracts 2010;Molecular and clinical determinants of survival following relapse after curative treatment of stage II-III colon cancer. Results of the translational study on the PETACC 3 trial ;Rationale;Objectives;Stratification: Stage II vs. III Center;PETACC-3: DFS Not Significantly Improved With FOLFIRI in Stage III;PETACC3 trial: Patient Distribution;Relapsing Patients Characteristics;Univariate Analysis for SARin the marker set (N=392);Multivariate Analysis for SARin the marker set (N=392);SAR according to BRAF mutation status;Conclusions;12.3% of patients pr